Dosage form for administering calcium antagonist nicardipine
US5096716A · kind A · utility
8Cited by
9References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 1990 |
| Grant date | Mar 17, 1992 |
| Priority date | — |
| Expiry date | May 18, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A dosage form is disclosed comprising a member selected from the group consisting of nicardipine and its pharmaceutically acceptable salts for administering to a patient in need of cardiovascular therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.